AzTrials
AzTrials

StrokeNCT07706621

Pilot Trial of Robotic Hand Therapy After Stroke

A study testing robotic-assisted hand therapy and Action-observation therapy & Education in people with Stroke, run by Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal at 1 site in Canada.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This pilot study will test whether the GRIP program-a soft robotic glove with virtual-reality training-can improve hand and arm function in adults undergoing inpatient rehabilitation after a recent stroke. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Stroke
What is being tested?
robotic-assisted hand therapy and Action-observation therapy & Education
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteCanada
Study dates
1 Aug 2026to Jul 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • First unilateral stroke (<6-month post-stroke at enrollment)
  • ≥18 years old
  • Hand sensorimotor impairments
  • Able to understand and follow a two-step instruction
  • Admitted to the rehabilitation center and participating in the stroke program

Who cannot join

  • Severe spasticity (score ≥3 on the Modified Ashworth Scale)
  • Unilateral spatial neglect
  • Moderate to severe hand pain
  • Significant motor impairment of the fingers (active finger flexion/extension less than 10°)
  • Any medical condition that may interfere with participation

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Canada1 site
  • Institut de réadaptation Gingras-Lindsay-de-Montréal

    Montreal, Quebec, H3S 2J4

    Marika Demers, PhD, 514 343-6111 ext. 30897, marika.demers@umontreal.ca

    Johanne Higgins, PhD, 514 343-6111 ext. 29924, johanne.higgins@umontreal.ca

Other trials in Canada

About this study

Official title: Robotic-Assisted Hand Therapy for Neurorehabilitation in Adults With Hand Sensorimotor Impairments Following a Stroke: A Pilot Randomized Controlled Trial

This pilot study will test whether the GRIP program-a soft robotic glove with virtual-reality training-can improve hand and arm function in adults undergoing inpatient rehabilitation after a recent stroke. About 20 participants will be randomly assigned to either the GRIP program or action-observation therapy with education, in addition to usual care. The study will assess motor improvement, safety, and acceptability over approximately six weeks.

Read the detailed description

The goal of this pilot clinical trial is to determine whether the Glove for Rehabilitation and Interactive Practice (GRIP) program can help improve hand and arm movement in adults who have difficulty using their hand after a recent stroke. The GRIP program uses a soft robotic glove and a virtual reality training platform. It is added to the usual rehabilitation care that participants already receive.

The main questions this study aims to answer are:

  • Does the GRIP program help improve hand and arm movement?
  • Is the GRIP program safe?
  • Do participants find the GRIP program acceptable, comfortable, and engaging? (qualitatively).

Researchers will compare the Glove for Rehabilitation and Interactive Practice (GRIP) program with action-observation therapy and education. Action-observation therapy means watching videos of hand movements and then practicing the same movements. Both groups will also receive their usual rehabilitation care. This study will include about 20 adults who are in an inpatient rehabilitation program after a stroke and who have difficulty using their hand.

Conditions
Stroke
Being tested
robotic-assisted hand therapy, Action-observation therapy & Education
Keywords
stroke, cerebrovascular accident, virtual reality, virtual environment, robotics, exosqueleton, finger, hand, grasp, manual dexterity, prehension, upper limb, motor recovery, subacute
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • robotic-assisted hand therapyDevice

    Also called hand exosqueleton coupled with a virtual reality program

    Participants will receive the GRIP program in addition to usual rehabilitation care. The program uses a soft robotic glove worn on the affected hand together with a non-immersive virtual-reality system that displays hand exercises and a virtual hand that moves with the participant's real movements. The glove can provide assistance or resistance to support grasping practice and strengthening. Training focuses on repeated grasping tasks and strategies to increase use of the affected hand in daily activities. The program includes ten supervised 30-minute sessions over two weeks.

  • Action-observation therapy & EducationBehavioural

    Also called Education, Action-Observation Therapy

    Participants will receive usual rehabilitation care plus action-observation therapy (AOT). They will complete ten self-directed 30-minute AOT sessions over two weeks. Each session consists of repeated cycles of watching short videos of hand movements and then attempting to reproduce those movements with the affected hand. Videos will match the grasp types practiced in the intervention arm. Participants will also attend three individual education sessions on post-stroke arm and hand recovery, including strategies to increase use of the affected hand in daily activities.

Study groups in NCT07706621
Study groupRoleWhat they receive
Glove for Rehabilitation and Interactive Practice (GRIP) programExperimental10 participants will be randomly assigned to this group.
Receives: Device: robotic-assisted hand therapy
Action-Observation Therapy (AOT) and EducationActive comparator10 participants will be randomly assigned to this group.
Receives: Behavioral: Action-observation therapy & Education

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Fugl-Meyer Assessment Upper Extremity (FMA-UE)

    It is a stroke-specific, performance-based impairment index designed to measure upper extremity motor recovery after stroke.

    Measured: At enrollment , post-intervention (at 2 weeks), and 1 month follow-up (at 6 weeks)

Secondary outcomes (1)
  1. Action Research Arm Test

    Observational measure that examines upper limb functional recovery

    Measured: At enrollment, post-intervention (at 2 weeks), 1 month follow-up (at 6 weeks)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Jul 2026
  2. Study start1 Aug 2026 (estimated)
  3. Primary completionJul 2027 (estimated)
  4. Study completionJul 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07706621
Sponsor's protocol ID
2026-2490
Status last verified
Jul 2026
First submitted
9 Jul 2026
Last updated
16 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing robotic-assisted hand therapy and Action-observation therapy & Education in people with Stroke, run by Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 16 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Johanne Higgins, PhD (514 343-6111 ext. 29924, johanne.higgins@umontreal.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Fugl-Meyer Assessment Upper Extremity (FMA-UE) (time frame: At enrollment , post-intervention (at 2 weeks), and 1 month follow-up (at 6 weeks)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in